| Approved product | Type | EBOV | SUDV | BDBV | TAFV |
|---|---|---|---|---|---|
| Ervebo | Vaccine | ● | ○ | ○ | ○ |
| Zabdeno + Mvabea | Vaccine | ● | ○ | ○ | ○ |
| Inmazeb | Therapeutic | ● | ○ | ○ | ○ |
| Ebanga | Therapeutic | ● | ○ | ○ | ○ |
● = covered by an approved product · ○ = not covered by any approved product (as of May 2026)
Source: FDA + EMA labels, WHO Prequalification. The 2026 PHEIC strain (Bundibugyo) is not covered by any approved product.
Methodology and per-product details →